Matches in SemOpenAlex for { <https://semopenalex.org/work/W3090314487> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W3090314487 endingPage "30" @default.
- W3090314487 startingPage "22" @default.
- W3090314487 abstract "Background: There is a need for effective, well tolerated and affordable drug for chronic migraine prophylaxis in low socioeconomic countries.
 Objective: To study the efficacy and safety of propranolol and sodium valproate (a food and drug administration approved and widely used treatment for prevention of migraine) as a prophylactic treatment in chronic migraine (CM) patients and to compare their efficacy and safety to each other.
 Methods: In this single center, open labeled clinical trial, 40 patients with CM were subdivided into two group: group 1 (n=20) treated with propranolol and group 2 (n=20) treated with sodium valproate. Patients maintained headache diaries over a 1-month baseline period and a 6- month active study period. The evaluation of the treatment was done after 3 and 6 months of the initiation of the treatment. The efficacy measures were evaluation of monthly attacks frequency and attacks severity using VAS of pain (visual analogue scale. Disability and impact of migraine were evaluated using Migraine assessment disability scale (MIDAS) and Headache Impact Test (HIT-6). Throughout the study, patients were monitored for any symptoms or signs of adverse effects.
 Results: Of 40 patients participated in this study (mean age, 33.48; females 72.5%). At the 6th month, the study was completed by 27 patients (propranolol; n=14 and sodium valproate; n=13). Between 55 and 62% of both groups reported more than 50% reduction in monthly attacks frequency. In both groups, there was significant reduction of VAS of pain scores. Both groups showed significant improvement of HIT-6 and MIDAS scores. Before the start of treatment, 85% to 100% of patients in both groups had severe MIDAS and HIT-6 scores. At the end of the study, only 35.7% of propranolol group and 30.8 of sodium valproate group showed severe MIDAS scores and 50% of propranolol group and 40% of sodium valproate group reported severe HIT-6 scores. 55% (n=11) of patients in propranolol reported AEs related to treatment compared to 75% (n=15) in the sodium valproate group. A higher proportion of patients discontinued the treatment because of AEs in Na valproate group compared to sodium valproate group with no statistically significant difference in between (20% vs. 5%, respectively).
 Conclusions: Propranolol and sodium valproate demonstrated similar efficacy and tolerability in the prophylactic treatment of CM." @default.
- W3090314487 created "2020-10-08" @default.
- W3090314487 creator A5004461116 @default.
- W3090314487 creator A5025540998 @default.
- W3090314487 creator A5045311194 @default.
- W3090314487 creator A5064669301 @default.
- W3090314487 creator A5089022264 @default.
- W3090314487 date "2020-10-02" @default.
- W3090314487 modified "2023-10-11" @default.
- W3090314487 title "Sodium Valproate versus Propranolol in Chronic Migraine Prophylaxis" @default.
- W3090314487 cites W1913695249 @default.
- W3090314487 cites W1967343661 @default.
- W3090314487 cites W1967364781 @default.
- W3090314487 cites W1970386351 @default.
- W3090314487 cites W1979174673 @default.
- W3090314487 cites W1991277549 @default.
- W3090314487 cites W1995699180 @default.
- W3090314487 cites W2007410119 @default.
- W3090314487 cites W2015197538 @default.
- W3090314487 cites W2017637293 @default.
- W3090314487 cites W2074813714 @default.
- W3090314487 cites W2075075391 @default.
- W3090314487 cites W2109048238 @default.
- W3090314487 cites W2118912931 @default.
- W3090314487 cites W2120263268 @default.
- W3090314487 cites W2124620979 @default.
- W3090314487 cites W2146670337 @default.
- W3090314487 cites W2156341109 @default.
- W3090314487 cites W2186688509 @default.
- W3090314487 cites W2242550496 @default.
- W3090314487 cites W2556396441 @default.
- W3090314487 cites W2560007356 @default.
- W3090314487 doi "https://doi.org/10.9734/indj/2020/v14i330130" @default.
- W3090314487 hasPublicationYear "2020" @default.
- W3090314487 type Work @default.
- W3090314487 sameAs 3090314487 @default.
- W3090314487 citedByCount "1" @default.
- W3090314487 countsByYear W30903144872023 @default.
- W3090314487 crossrefType "journal-article" @default.
- W3090314487 hasAuthorship W3090314487A5004461116 @default.
- W3090314487 hasAuthorship W3090314487A5025540998 @default.
- W3090314487 hasAuthorship W3090314487A5045311194 @default.
- W3090314487 hasAuthorship W3090314487A5064669301 @default.
- W3090314487 hasAuthorship W3090314487A5089022264 @default.
- W3090314487 hasBestOaLocation W30903144871 @default.
- W3090314487 hasConcept C126322002 @default.
- W3090314487 hasConcept C14184104 @default.
- W3090314487 hasConcept C197934379 @default.
- W3090314487 hasConcept C2778151854 @default.
- W3090314487 hasConcept C2778541695 @default.
- W3090314487 hasConcept C2910587157 @default.
- W3090314487 hasConcept C42219234 @default.
- W3090314487 hasConcept C535046627 @default.
- W3090314487 hasConcept C71924100 @default.
- W3090314487 hasConceptScore W3090314487C126322002 @default.
- W3090314487 hasConceptScore W3090314487C14184104 @default.
- W3090314487 hasConceptScore W3090314487C197934379 @default.
- W3090314487 hasConceptScore W3090314487C2778151854 @default.
- W3090314487 hasConceptScore W3090314487C2778541695 @default.
- W3090314487 hasConceptScore W3090314487C2910587157 @default.
- W3090314487 hasConceptScore W3090314487C42219234 @default.
- W3090314487 hasConceptScore W3090314487C535046627 @default.
- W3090314487 hasConceptScore W3090314487C71924100 @default.
- W3090314487 hasLocation W30903144871 @default.
- W3090314487 hasOpenAccess W3090314487 @default.
- W3090314487 hasPrimaryLocation W30903144871 @default.
- W3090314487 hasRelatedWork W2041859833 @default.
- W3090314487 hasRelatedWork W2058945587 @default.
- W3090314487 hasRelatedWork W2107697672 @default.
- W3090314487 hasRelatedWork W2122311626 @default.
- W3090314487 hasRelatedWork W2793051137 @default.
- W3090314487 hasRelatedWork W2961287808 @default.
- W3090314487 hasRelatedWork W3015052705 @default.
- W3090314487 hasRelatedWork W3038802552 @default.
- W3090314487 hasRelatedWork W3160976852 @default.
- W3090314487 hasRelatedWork W4290096750 @default.
- W3090314487 isParatext "false" @default.
- W3090314487 isRetracted "false" @default.
- W3090314487 magId "3090314487" @default.
- W3090314487 workType "article" @default.